Trademarkia Logo

Canada

C$
ZAVSPRO
REGISTERED

on 5 Jul 2024

Last Applicant/ Owned by

PFIZER IRELAND PHARMACEUTICALS

Operations Support GroupRingaskiddy, County Cork,

IE

Serial Number

2277909 filed on 29th Aug 2023

Registration Number

TMA1243432 registered on 5th Jul 2024

Registration expiry Date

5th Jul 2034

Correspondent Address

TORYS LLP

SUITE 300079 WELLINGTON ST. W.BOX 270, TD CENTRETORONTO

ONTARIO

CA

M5K1N2

ZAVSPRO

Trademark usage description

pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of psychiatric diseases, namely, mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of neurodegenerative, nerve, neuromuscular and brain diseases and disorders, namely muscular dystrophy; Pharmaceutical preparations for the treatment of bone growth disorders; Pharmaceutical preparations for the treatment of the central nervous system, namely brain diseases and central nervous system movement disorders; Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, and blood diseases and disorders; Pharmaceutical preparations for the treatment of auto-immune diseases and disorders, namely rheumatoid arthritis, systemic lupus, alopecia areata, and systemic sclerosis; Pharmaceutical preparations for the treatment of hypertension, menopause symptoms, obesity, stroke, arthritis, and pain; Pharmaceutical preparations for the treatment of cancer; Anti-infectives, anti-inflammatories, anti-viral agents, human vaccines; Pharmaceutical preparations for use in discouraging smoking habits; Pharmaceutical preparations for the treatment of kidney and liver disease and disorders; Pharmaceutical preparations for the treatment of diseases and disorders of the endocrine system, namely growth and thyroid disorders; Pharmaceutical preparations for the treatment of inflammatory diseases, namely inflammatory bowel diseases, inflammatory joint diseases, inflammatory connective tissue diseases, inflammatory muscle diseases and disorders; Pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely cachexia, diabetes, hypoglycemia, muscular dystrophy, obesity, sickle cell disease, non-alcoholic steatohepatitis (NASH) and anemia; Pharmaceutical preparations for the treatment of skin and dermatological diseases and conditions, namely eczema, atopic dermatitis, psoriasis, bacterial skin infections, and viral skin infections; pharmaceutical preparations for the treatment of plasma cell dyscrasias; pharmaceutical preparations for the treatment of migraine.


Classification kind code

12

Mark Details


Serial Number

2277909

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 190
on 5th Jul 2024
Registration Pending
Submitted for opposition 55
on 5th Jul 2024
Registered
Submitted for opposition 42
on 17th Apr 2024
Advertised
Submitted for opposition 27
on 21st Mar 2024
Approval Notice Sent
Submitted for opposition 26
on 21st Mar 2024
Approved
Submitted for opposition 22
on 16th Mar 2024
Search Recorded
Submitted for opposition 287
on 14th Sept 2023
Pre-Assessment Letter Sent
Submitted for opposition 30
on 29th Aug 2023
Filed
Submitted for opposition 1
on 29th Aug 2023
Created
Submitted for opposition 31
on 29th Aug 2023
Formalized